Chiara Gallio

8PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2026
On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.

|Oct 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.

Carlo Signorelli, Michele Basso, Maria Alessandra Calegari

|Aug 14, 2025
Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and Combinations.

Chiara Gallio, Luca Esposito, Alessandro Passardi

|Jun 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study.

Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone

|Oct 26, 2024
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience.

Laura Matteucci, Francesco Giulio Sullo, Chiara Gallio

|Jul 27, 2024
PD-L1 Expression in Paired Samples of Rectal Cancer.

Mina Coussement, Roberta Fazio, Alessandro Audisio

Pageof 2

Frequent Collaborators

5 joint publications

Alessandro Passardi

4 joint publications

Alessandro Bittoni

3 joint publications

Ina Valeria Zurlo

3 joint publications

Jessica Lucchetti